by Erin Edgar to David Shoemaker at 1:35 p.m. EST on August 14, 2012.The blunt-spoken general had: Thomas E. Ricks, Fiasco (New York: The Penguin
Press, 2006), 313.
With Colonel Edgar’s encouragement: Email with the subject line “Theranos
(UNCLASSIFIED)” sent by David Shoemaker to Penny Keller and Judith Yost,
copying Erin Edgar and Robert Miller, at 3:34 p.m. EST on August 15, 2012.
The response he got: Email with the subject line “RE: Theranos (UNCLASSIFIED)”
sent by Penny Keller to David Shoemaker, copying Erin Edgar, at 1:36 p.m.
EST on August 16, 2012.
When he confronted Colonel Edgar: Email with the subject line “Re: Theranos
(UNCLASSIFIED)” sent by Erin Edgar to David Shoemaker at 7:23 p.m. EST
on August 16, 2012.
At 3:00 p.m. sharp on August 23, 2012: Email with the subject line “RE: Theranos
followup (UNCLASSIFIED)” sent by David Shoemaker to Alberto Gutierrez at
10:58 a.m. EST on August 20, 2012.
- LIGHTING A FUISZ
The doorbell at 1238 Coldwater Canyon Drive: Affidavit of service of summons
notarized on October 31, 2011.
The couple had purchased it: Theranos, Inc. et al. v. Fuisz Pharma LLC et al.,
deposition of Lorraine Fuisz, June 11, 2013, 111; Realtor.com.
He had sold it: “Biovail to Buy Fuisz Technologies for $154 Million,” Dow Jones,
July 27, 1999.
It was now part of: “Biovail to Merge with Valeant,” New York Times, June 21,
2010.
The lawsuit had been filed: Theranos, Inc. et al. v. Fuisz Pharma LLC et al.,
complaint filed on October 26, 2011, 7–10.
The first and only time Fuisz: Email with the subject line
“http://www.freshpatents.com/Medical-device-for-analyte-monitoring-and-
drug-delivery-dt20060323ptan20060062852.php” sent by Richard Fuisz to
John Fuisz, copying Joe Fuisz, at 8:31 a.m. EST on July 3, 2006.
John replied that McDermott: Email with the subject line “Re:
http://www.freshpatents.com/Medical-device-for-analyte-monitoring-and-
drug-delivery-dt20060323ptan20060062852.php” sent by John Fuisz to
Richard Fuisz, copying Joe Fuisz, at 9:34 a.m. EST on July 3, 2006.
John had no reason to wish: Theranos, Inc. et al. v. Fuisz Pharma LLC et al.,